Julia Raitanen, MSc
Department of Biomedical Imaging and Image-guided Therapy (Division of Nuclear Medicine)
Position: PHD Student
ORCID: 0000-0002-8115-3062
T +43 1 40400 78300
julia.raitanen@meduniwien.ac.at
Keywords
Drug Evaluation, Preclinical; Oncology; Radiobiology; Radiochemistry; Radiopharmaceuticals
Research interests
My main research interest lies in (targeted) radiotherapy of cancer, including novel approaches of Auger Electron Therapy. In this context, I currently focus on therapeutic efficacy studies in 2D and 3D cell culture systems.
Selected publications
- Raitanen, J. et al. (2023) ‘Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines’, Cells, 12(3), p. 360. Available at: http://dx.doi.org/10.3390/cells12030360.
- Balber, T. et al. (2022) ‘Experimental Nuclear Medicine Meets Tumor Biology’, Pharmaceuticals, 15(2), p. 227. Available at: http://dx.doi.org/10.3390/ph15020227.
- Bamminger, K. et al. (2022) ‘Rapid, high-yield enzymatic synthesis of n.c.a. 6-[18F]fluorodopamine (6-[18F]FDA) for in vivo application’, Nuclear Medicine and Biology, 114–115, pp. 189–197. Available at: http://dx.doi.org/10.1016/j.nucmedbio.2022.07.001.
- Godbersen, G.M. et al. (2023) ‘Task-evoked metabolic demands of the posteromedial default mode network are shaped by dorsal attention and frontoparietal control networks’, eLife, 12. Available at: http://dx.doi.org/10.7554/elife.84683.